Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma

被引：0
|
作者：
Massarelli, Erminia
Ginsberg, Lawrence E.
Lin, Heather
Tran, Hai T.
Lee, J. Jack
Williams, Michelle D.
Blumenschein, George R.
Lu, Charles
Kies, Merrill S.
Papadimitrakopoulou, Vassiliki
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6067
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase II study of ispinesib in patients (PTS) with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC)
    Tang, Patricia
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Colevas, A. Dimitrios
    Johnson, Caitlin
    Pond, Greg R.
    Winquist, Eric
    ANNALS OF ONCOLOGY, 2006, 17 : 186 - 186
  • [42] Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Degardin, M
    Bastit, P
    Rolland, F
    Armand, JP
    Chevallier, B
    VanGlabbeke, M
    Boudillet, J
    Tresca, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 843 - 843
  • [43] Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Shin, DM
    Khuri, FR
    Glisson, BS
    Ginsberg, L
    Papadimitrakopoulou, VM
    Clayman, G
    Lee, JJ
    Ang, KK
    Lippman, SM
    Hong, WK
    CANCER, 2001, 91 (07) : 1316 - 1323
  • [44] A phase II trial of docetaxel plus cisplatin in recurrent and/or metastatic non-squamous cell carcinoma of head and neck
    Imamura, Y.
    Kiyota, N.
    Tanaka, K.
    Hayashi, H.
    Ota, I.
    Nario, K.
    Hirano, S.
    Arai, A.
    Iwae, S.
    Onoe, T.
    Minami, S.
    Shimada, T.
    Yane, K.
    Yamazaki, T.
    Nagatani, Y.
    Toyoda, M.
    Otsuki, N.
    Nibu, K-I.
    Minami, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [45] Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma
    Ferrarotto, Renata
    William, William N., Jr.
    Tseng, Jennifer E.
    Marur, Shanthi
    Shin, Dong M.
    Murphy, Barbara
    Cohen, Ezra E. W.
    Thomas, Christopher Y.
    Willey, Richard
    Cosaert, Jan
    Harun, Nusrat
    Lee, J. Jack
    Wistuba, Ignacio W.
    Haddad, Robert I.
    Glisson, Bonnie S.
    ORAL ONCOLOGY, 2018, 82 : 83 - 90
  • [46] Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Degardin, M
    Cappelaere, P
    Krakowski, I
    Fargeot, P
    Cupissol, D
    Brienza, S
    ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B, 1996, 32B (04): : 278 - 279
  • [47] Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03
    Fayette, Jerome
    Guigay, Joel
    Le Tourneau, Christophe
    Degardin, Marian
    Peyrade, Frederic
    Neidhardt, Eve-Marie
    Sablin, Marie-Paule
    Even, Caroline
    Orlandini, Florence
    Juzyna, Beata
    Bellera, Carine
    ONCOTARGET, 2017, 8 (31) : 51830 - 51839
  • [48] Multicenter phase II trial of palbociclib, a selective cyclin dependent kinase (CDK) 4/6 inhibitor, and cetuximab in platinum-resistant HPV unrelated (-) recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC).
    Adkins, Douglas
    Oppelt, Peter John
    Ley, Jessica C.
    Trinkaus, Kathryn
    Neupane, Prakash C.
    Sacco, Assuntina Gesualda
    Palka, Kevin A.
    Worden, Francis P.
    Grilley-Olson, Juneko E.
    Maggiore, Ronald John
    Ernst, Conor
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Lasniska, Izabela
    Kolenda, Tomasz
    Teresiak, Anna
    Lamperska, Katarzyna M.
    Galus, Lukasz
    Mackiewicz, Jacek
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 290 - 303
  • [50] A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma
    McPherson, Victor
    Reardon, Brendan
    Bhayankara, Aravind
    Scott, Sasinya N.
    Boyd, Mariel E.
    Garcia-Grossman, Ilana R.
    Regazzi, Ashley M.
    McCoy, Asia S.
    Kim, Philip H.
    Al-Ahmadie, Hikmat
    Ostrovnaya, Irina
    Roth, Andrew J.
    Farooki, Azeez
    Berger, Michael F.
    Rosenberg, Jonathan E.
    Solit, David B.
    Van Allen, Eliezer
    Milowsky, Matthew I.
    Bajorin, Dean F.
    Iyer, Gopa
    CANCER, 2020, 126 (20) : 4532 - 4544
12345